Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 151 for “"MASLD"”.

  1. Νεότερες θεραπευτικές στρατηγικές στη MASLD και καρδιαγγειακές επιδράσεις αυτών

    Η MASLD (Metabolic dysfunction-associated steatotic liver disease) είναι η συχνότερη χρόνια νόσος του ήπατος με τον επιπολασμό της να αυξάνεται με ταχείς ρυθμούς. Οι κυριότερες ηπατικές επιπλοκές της που συμβάλλουν δραστικά στην μείωση του προσδόκιμου ζωής είναι η κίρρωση και ο ηπατοκυτταρικός …

    athens Repository record for Νεότερες θεραπευτικές στρατηγικές στη MASLD και καρδιαγγειακές επιδράσεις αυτών (opens in a new tab)

  2. Epigenetic therapy based on micrornas inhibition for the amelioration of masld phenotype

    … dysfunction-associated steatotic liver disease (MASLD) is currently the most prevalent liver disorder worldwide. In Europe, around 25% of people suffer from this disease. It is strongly associated with several comorbidities, including obesity, type 2 diabetes mellitus, and metabolic syndrome. …

    sevilla Repository record for Epigenetic therapy based on micrornas inhibition for the amelioration of masld phenotype (opens in a new tab)

  3. Systematic review of the microRNAs association with metabolic dysfunction associated steatotic liver disease (MASLD)

    Εισαγωγή: Η μη αλκοολική λιπώδης νόσος του ήπατος (NAFLD) είναι μια νοσηρότητα που χαρακτηρίζεται από υπερβολική συσσώρευση λιπιδίων στο ήπαρ. Θεωρείται ένας τύπος νοσηρότητας του μεταβολικού συνδρόμου και αυξάνει τον κίνδυνο καρδιαγγειακής νόσου. Ο κίνδυνος καρδιαγγειακής νόσου είναι αυξημένος στη …

    athens Repository record for Systematic review of the microRNAs association with metabolic dysfunction associated steatotic liver disease (MASLD) (opens in a new tab)

  4. The Role of TMEM41B in VLDL Secretion and the Development and Progression of MASLD

    … dysfunction-associated steatotic liver disease (MASLD) is an increasingly prevalent chronic liver disease characterized by asymptomatic hepatic lipid accumulation. Without treatment, MASLD progresses to metabolic dysfunction associated steatohepatitis (MASH), as excessive lipid droplet (LD) …

    ku Repository record for The Role of TMEM41B in VLDL Secretion and the Development and Progression of MASLD (opens in a new tab)

  5. Investigation of the Regulation and Pathological Role for Macrophage Sting in MASLD and Insulin Resistance

    … dysfunction-associated steatotic liver disease (MASLD), formerly termed as non-alcoholic fatty liver disease (NAFLD), is characterized by the excessive fat deposition in hepatocytes and has the potential to progress to metabolic dysfunction-associated steatohepatitis (MASH) when there is overt …

    tamu Repository record for Investigation of the Regulation and Pathological Role for Macrophage Sting in MASLD and Insulin Resistance (opens in a new tab)

  6. Epigenetic and Transgenerational Influences on Metabolic dysfunction-associated Steatotic Liver Disease (MASLD) Susceptibility and Management

    … Dysfunction-Associated Steatotic Liver Disease (MASLD) is high and often associated with conditions such as obesity, type 2 diabetes, and dyslipidemia. This study hypothesizes that reduced parental energy expenditure will negatively influence the metabolic health of the female offspring. …

    ku Repository record for Epigenetic and Transgenerational Influences on Metabolic dysfunction-associated Steatotic Liver Disease (MASLD) Susceptibility and Management (opens in a new tab)

  7. The role of hepatocyte specific eNOS and exercise in regulation of hepatic de novo lipogenesis and MASLD

    … Dysfunction-Associated Steatotic Liver Disease (MASLD) remains poorly understood. In this study, we investigated the role of hepatocellular eNOS in regulating hepatic lipid accumulation, with a particular focus on one of the most prominent contributors to the development of this disease, de novo …

    missouri Repository record for The role of hepatocyte specific eNOS and exercise in regulation of hepatic de novo lipogenesis and MASLD (opens in a new tab)

  8. Impact of hepatocyte-specific Dio3 inactivation on energy metabolism following fasting and WD-induced MASLD in mice

    … dysfunction-associated steatotic liver disease (MASLD). Based on this, we hypothesized that hepatic TH availability and signaling critically influence systemic energy homeostasis. To test this, we used a hepatocyte-specific Dio3 knockout model (Alb-Cre; Dio3fl/fl; HepDio3KO) to locally manipulate …

    fu-berlin Repository record for Impact of hepatocyte-specific Dio3 inactivation on energy metabolism following fasting and WD-induced MASLD in mice (opens in a new tab)

  9. The MASLD and MASH Hispanic disparity: adult and pediatric prevalences, contributing factors, and outcomes of disease and therapies

    … dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. This disease is known to disproportionately impact Hispanic populations, with adult Hispanic populations in the U.S. experiencing a greater prevalence of MASLD and greater burden of MASLD …

    bu Repository record for The MASLD and MASH Hispanic disparity: adult and pediatric prevalences, contributing factors, and outcomes of disease and therapies (opens in a new tab)

  10. GENOME-WIDE ASSOCIATION STUDY OF NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS IN MASLD: EVIDENCE FROM AN ITALIAN POPULATION

    Metabolic Associated Steatotic Liver Disease (MASLD) is the most prevalent cause of chronic liver disease worldwide and a significant risk factor for cirrhosis and hepatocellular carcinoma (HCC). Despite its pathogenesis being determined by both environmental and genetic determinants, the genetic …

    milano Repository record for GENOME-WIDE ASSOCIATION STUDY OF NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS IN MASLD: EVIDENCE FROM AN ITALIAN POPULATION (opens in a new tab)

  11. Impact of mtDNA Signature on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Progression and Cardiometabolic Outcomes in Mice

    … dysfunction-associated steatotic liver disease (MASLD) emerging as both a prevalent comorbidity and an independent risk factor for adverse outcomes. While diet and lifestyle are established contributors, variation in mitochondrial DNA (mtDNA) has been linked to differences in bioenergetic …

    queens Repository record for Impact of mtDNA Signature on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Progression and Cardiometabolic Outcomes in Mice (opens in a new tab)

  12. Ρίχνοντας φως στη σχέση MASLD και Σακχαρώδους Διαβήτη τύπου 1: παθοφυσιολογία και νέες θεραπευτικές στρατηγικές: Μία βιβλιογραφική ανασκόπηση

    … που σχετίζεται με μεταβολική δυσλειτουργία (MASLD) περιλαμβάνει ένα ευρύ φάσμα ηπατικών παθήσεων που κυμαίνονται από την απλή στεάτωση έως τη στεατοηπατίτιδα που σχετίζεται με τη μεταβολική δυσλειτουργία (MASH), η οποία μπορεί να εξελιχθεί σε κίρρωση και ηπατοκυτταρικό καρκίνωμα (HCC). Μέχρι …

    athens Repository record for Ρίχνοντας φως στη σχέση MASLD και Σακχαρώδους Διαβήτη τύπου 1: παθοφυσιολογία και νέες θεραπευτικές στρατηγικές: Μία βιβλιογραφική ανασκόπηση (opens in a new tab)

  13. Μη κανονική σηματοδότηση Notch στη στεατοτική ηπατική νόσο σχετιζόμενη με μεταβολική δυσλειτουργία (MASLD) και στο ηπατοκυτταρικό καρκίνωμα (HCC)

    … Dysfunction-Associated Steatotic Liver Disease, MASLD) και η μετέπειτα φλεγμονώδης μορφή της, η στεατοηπατίτιδα που σχετίζεται με μεταβολική δυσλειτουργία (Metabolic Dysfunction-Associated Steatohepatitis, MASH), ευθύνονται για το αυξανόμενο ποσοστό των νέων διαγνώσεων HCC. Ωστόσο, οι αξιόπιστοι …

    athens Repository record for Μη κανονική σηματοδότηση Notch στη στεατοτική ηπατική νόσο σχετιζόμενη με μεταβολική δυσλειτουργία (MASLD) και στο ηπατοκυτταρικό καρκίνωμα (HCC) (opens in a new tab)

  14. Papel de las vesículas extracelulares en la progresión de la enfermedad hepática esteatótica asociada a disfunción metabólica (MASLD)

    Antecedentes/Objetivos: MASLD comprende un espectro de patologías, que van desde la esteatosis hasta el carcinoma hepatocelular. Por lo tanto, identificar las primeras etapas es importante para evitar la progresión de la enfermedad. Así Vesículas extracelulares y microRNAs, importantes en la …

    brazil-ufrgs Repository record for Papel de las vesículas extracelulares en la progresión de la enfermedad hepática esteatótica asociada a disfunción metabólica (MASLD) (opens in a new tab)

  15. Molecular characterization of metaflammation in a triple-transgenic pig model of metabolic dysfunction-associated steatotic liver disease (MASLD)

    … dysfunction-associated fatty liver disease (MASLD) is one of the most common liver diseases worldwide. Animal models are essential for medical research, drug development and preclinical tests. Pigs, given their physiological and anatomical similarities to humans, offer a distinct advantage as …

    liege Repository record for Molecular characterization of metaflammation in a triple-transgenic pig model of metabolic dysfunction-associated steatotic liver disease (MASLD) (opens in a new tab) Embargoed

  16. Integrated computational-experimental approach to identify and optimise drug therapy for metabolic dysfunction-associated steatotic liver disease

    … dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide, affecting more than one in four people, and is the leading indication for liver transplantation. Disease progression to cirrhosis and liver-related outcomes is highly variable and there is a …

    edinburgh Repository record for Integrated computational-experimental approach to identify and optimise drug therapy for metabolic dysfunction-associated steatotic liver disease (opens in a new tab)

  17. Circadian rhythm and misalignment in the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD): an experimental medicine approach

    … dysfunction associated steatotic liver disease (MASLD) is the most common liver disease worldwide and is associated with a high global burden of liver- and cardiovascular-related morbidity and mortality. Understanding the role of circadian rhythm in human liver metabolism will therefore advance …

    oxford Restricted access

Page 1 of 8